The study of "dihydropyrimidinase related proteins (DRPs)" expression changes influence in malignant astrocytoma brain tumor

Iranian Journal of Cancer Prevention

Volumn 7, Issue 3, 2014, Pages 130-136

  Pooladi, Mehdi ^a,b   Rezaei Tavirani, Mostafa ^a   Hashemi, Mehrdad ^c   Hesami Tackallou, Saeed ^d   Khaghani Razi Abad, Solmaz ^a,b   Moradi, Afshin ^a   Zali, Ali Reza ^a   Mousavi, Masoumea ^a   Rakhshan, Azadeh ^a   Firozi Dalvand, Leila ^a   Omidi, Roghaye ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Asterocytoma; DRP and 2DG electrophoresis; Proteomics

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DIHYDROPYRIMIDINASE RELATED PROTEIN 3; GLYCOGEN SYNTHASE KINASE 3; PROTEOME; UNCLASSIFIED DRUG;

ADULTHOOD; ARTICLE; ASTROCYTOMA; BRADFORD TEST; BRAIN DEVELOPMENT; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; NERVE CELL DIFFERENTIATION; PH; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REGULATORY MECHANISM; SPECTROPHOTOMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84907350300     PISSN: 20082401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hong LE, Wonodi I, Avila MT, Buchanan RW, McMahon RP, Mitchell BD, et al. Dihydropyrimidinase-related protein 2 (DRP2) gene and association to deficit and nondeficitschizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2005; 136(1):8-11.
2. Nakata K, Ujike H, Sakai A, Takaki M, Imamura T, Tanaka Y, et al. The human dihydropyrimidinaserelated protein 2 gene on chromosome 8p21 is associated withparanoid-type schizophrenia. Biol Psychiatry. 2003; 53(7):571-6.
3. Wang LH, and Strittmatter SM. A family of rat CRMP genes is differentially expressed in the nervous system. J Neurosci. 1996; 16(19):6197-207.
4. Byk T, Dobransky T, Cifuentes-Diaz C, Sobel A. dentification and molecular characterization of Unc-33 like phosphoprotein (Ulip), a putativemammalian homolog of the axonal guidanceassociated unc-33 gene product. J Neurosci. 1996; 16(2):688-701.
5. Kamata T, Daar IO, Subleski M, Copeland T, Kung HF, Xu RH. Xenopus CRMP-2 is an early response gene to neural induction. Brain Res Mol Brain Res. 1998; 57(2):201-10.
6. Byk T, Ozon S, Sobel A. The Ulip family phosphoproteins-common and specific properties. Eur J Biochem. 1998; 254(1):14-24.
7. Inagaki H, Kato Y, Hamajima N, Nonaka M, Sasaki M, Eimoto T. Differential expression of dihydropyrimidinase-related protein genes in developing and adultenteric nervous system. Histochem Cell Biol. 2000; 113(1):37-41.
8. Ujike H, Sakai A, Nakata K, Tanaka Y, Kodaka T, Okahisa Y, and et al. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetaminepsychosis. Ann N Y Acad Sci. 2006; 1074:90-6.
9. Kato Y, Hamajima N, Inagaki H, Okamura N, Koji T, Sasaki M, et al. Post-meiotic expression of the mouse dihydropyrimidinase-related protein 3 (DRP-3) gene during spermiogenesis. Mol Reprod Dev. 1998; 51(1):105-11.
10. Kunze W A, Furness J B. The enteric nervous systemand regulation of intestinal motility. Annu Rev Physiol. 1999; 61:117-42.
11. Tan M, Ma S, Huang Q, Hu K, Song B, Li M. GSK-3α/β-mediated phosphorylation of CRMP-2 regulates activity-dependent dendritic growth. J Neurochem. 2013; 125(5):685-97.
12. Koyama K, Sudo K, Nakamura Y. Isolation of 115 human chromosome8-specific expressedsequence tags by exon amplification. Genomics. 1995; 26(2):245-53.
13. Weitzdoerfer R, Fountoulakis M, Lubec G. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and-4 in fetal Down syndrome brain. J Neural Transm Suppl. 2001; (61):95-107.
14. Li W, Herman RK, Shaw JE. Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33. Genetics. 1992; 132(3):675-89.
15. Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G. Molecular diagnostics of Glioma: stste of the art. Acta Neuropathol. 2010; 120(5):567-84
16. Pooladi M, Sobhi S, Khaghani Razi Abad S, Hashemi M, Moradi A, Zali AR, et al. The investigation of Heat Shock Protein HSP70 expression change in human brain asterocytoma tumor. Iranian Journal of Cancer Prevention. 2013; 6:6-11.
17. Huse JT, Holland EC. Targeting brain cancer: advances in the olecular pathology of malignant Glioma and Medulloblastoma. Nat Rev Cancer. 2010; 10(5):319-31.
18. Plessis D. Primary Brain Tumours. Advances in clinical neuroscience and rehabilitaton. 2005; 4(6):17-9.
19. Xiong G, Xiao H, Lu J, Zhang D, Bi C, Peng L, et al. Differential protein expression in low-grade Astrocytomas and peritumoral human brain tissues. Neural Regeneration Research. 2010; 5(24):1915-20.
20. Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir EG. Attraction is elevated in the cerebrospinal fluid of patients with malignant Astrocytoma and mediated cell migration. Clin Cancer Res. 2006; 12(21):6331-6.
21. Klink B, Schlingelhof B, Klink M, Stout-Weider K, Patt S, Schrock E. Glioblastoma with Oligodendroglioma component-common origin of the different histological parts and genetic subclassification. Cell Oncol (Dordr). 2011; 34(3):261-75.
22. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P, Dhali S, et al. Investigation of serum proteome alterations in human Glioblastoma Multiforme. Proteomics. 2012; 12(14):2378-90.
23. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary GiIoblastoma. Am J Pathol. 2007; 170(5):1445-53.
24. Deighton RF, McGregor R, Kemp J, McCulloch J, Whittle IR. Glioma pathophysiology: insights emerging from proteomics. Brain Pathol. 2010;20(4):691-703.
25. Ardekani AM, Akhondi MM, Sadeghi MR. Application of genomic and prpteomic technologies to early detection of cancer. Arch Iran Med. 2008; 11(4):427-34.
26. Deighton RF, Short DM, McGregor RJ, Gow AJ, Whittle IR, McCulloch J. The utility of functional interaction and cluster analysis in CNS Proteomics. J Neurosci Methods. 2009; 180(2):321-9.
27. Khalil AA. Biomarker discovery: a proteomics approach for brain cancer profiling. Cancer Sci. 2007; 98(2):201-13.
28. Poon HF, Vaishnav RA, Getchell TV, Getchell ML, Butterfield DA. Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol Aging. 2006; 27(7):1010-9.
29. Chen A, Liao WP, Lu Q, Wong WS, Wong PT. Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shockcognate protein 70 pseudogene 1and tropomodulin 2 after focal cerebral ischemia in rats--aproteomics approach. Neurochem Int. 2007; 50(7-8):1078-86.
30. Veyrac A, Giannetti N, Charrier E, Reymond Marron I, Aguera M, Rogemond V, et al. Expression of collapsin response mediator proteins 1, 2 and 5 is differentially regulated in newly generated and mature neurons of the adult olfactory system. Eur J Neurosci. 2005; 21(10):2635-48.
31. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinaserelated protein 2, alpha-enolase and heat shock cognate 71. J Neurochem. 2002; 82(6):1524-32.
32. Bisgaard CF, Jayatissa MN, Enghild JJ, Sanchéz C, Artemychyn R, Wiborg O. Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatmentresistance and SNAP to stress resilience in the chronic mild stress model of depression. J Mol Neurosci. 2007; 32(2): 132-44.
33. Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature. 1995;376(6540):509-14.
34. Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Hamlat A, et al. Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach. Proteome Sci. 2011;9(1):16.
35. Fountoulakis M, Hardmaier R, Schuller E, Lubec G. Differences in protein level between neonatal and adult brain. Electrophoresis. 2000; 21(3):673-8.
36. Gu Y, Ihara Y. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. J Biol Chem. 2000; 275(24): 17917-20.
37. Choi YL, Kim CJ, Matsuo T, Gaetano C, Falconi R, Suh YL, et al. HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors. J Neurooncol. 2005;73(1):19-27.
38. Franzén B, Yang Y, Sunnemark D, Wickman M, Ottervald J, Oppermann M, et al. Dihydropyrimidinase related protein-2 as a biomarker for temperature and time dependent post mortem changes in the mouse brain proteome. Proteomics. 2003; 3(10):1920-9.
39. Ohtani-Kaneko R, Tazawa H, Yokosuka M, Yoshida M, Satoh M, Watanabe C. Suppressive effects of cadmium on neurons and affected proteins in cultured developingcortical cells. Toxicology. 2008; 253(1-3):110-6.
40. Arimura N, Ménager C, Kawano Y, Yoshimura T, Kawabata S, Hattori A, et al. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol. 2005; 25(22):9973-84.
41. Yin Y, Wang Y, Chen L, Han S, Zhao L, Luo Y, Li J. Tat-Collapsin Response Mediator Protein 2 (CRMP2) Increases the Survival of Neurons After NMDA Excitotoxity by Reducing the Cleavage of CRMP2. Neurochem Res. 2013; 2.
42. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell. 2005; 120(1):137-49.